Our Services
Medical Information
Helpful Resources
Published on: 9/26/2026
Voltaren gel (diclofenac sodium topical gel 1%) is a nonsteroidal anti-inflammatory medicine applied to the skin to relieve arthritis pain, stiffness, and swelling in joints such as the hands, wrists, elbows, knees, ankles, and feet, and it is typically used up to 4 times a day on any single affected joint. Dosing differs by body area, with about 2 grams per application for upper-body joints and 4 grams for lower-body joints, and there are daily limits plus a general 21-day limit for over-the-counter use without medical guidance. There are several important factors to consider, including who should avoid it, interactions with oral NSAIDs, and warning signs that your pain needs a different approach, so see below for the complete details.
Joint pain that keeps returning, spreads, or stops responding to topical treatment can point to something other than ordinary wear-and-tear arthritis, and guessing wrong can mean weeks of unnecessary discomfort. Take a free, instant, online symptom check to better understand what may be driving your pain and what sensible next steps look like.
Last reviewed for medical accuracy: 09/26/2026
Voltaren Gel (sometimes misspelled “voltarin”) is a topical anti-inflammatory medication that helps relieve pain and swelling in joints and soft tissues. It contains diclofenac sodium, a nonsteroidal anti-inflammatory drug (NSAID). Unlike pills, Voltaren Gel works directly where you apply it—on the skin over aching muscles, tendons, or joints.
Below, you’ll find clear, concise information on why and how to use Voltaren Gel, how often to apply it, and what to watch for. If at any point you feel unsure about your symptoms, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Voltaren Gel is approved and commonly used for:
Although Voltaren Gel can ease many kinds of joint and muscle pain, it’s not meant for deep-tissue massage or use on large areas of the body at once.
Note: Your total daily dose should not exceed 16 g for one joint area (e.g., one knee) and 32 g if treating two separate areas (e.g., both knees).
If symptoms persist beyond these timelines, or if your pain or swelling worsens, speak to a healthcare professional.
Most side effects are mild and localized:
Common (up to 1 in 10 users)
Uncommon or Rare
If you experience signs of a serious reaction (e.g., chest pain, difficulty breathing, severe rash), stop using Voltaren Gel and seek medical help immediately.
Always check with your doctor or pharmacist if you’re taking other NSAIDs or blood-thinning medications.
Topical Voltaren Gel has fewer drug interactions than oral NSAIDs, but caution is still advised if you’re on:
Tell your healthcare provider about all medicines and supplements you use.
Never delay seeking professional care for life-threatening or severe symptoms.
Voltaren Gel (voltarin) is a convenient option for localized joint and muscle pain, offering targeted relief with a lower risk of systemic effects. By following proper application steps, respecting dosage limits, and watching for any side effects, you can use Voltaren Gel safely and effectively. Always consult your doctor for any serious concerns or before starting new treatments.
(References)
* Seth BL. Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel or as an emulsion gel. Arzneimittelforschung. 1992 Feb;42(2):120-2. PMID: 1610419.
* Kienzler JL, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol. 2010 Jan;50(1):50-61. doi: 10.1177/0091270009336234. Epub 2009 Oct 19. PMID: 19841157.
* Derry S, Conaghan P, Da Silva JA, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016 Apr 22;4(4):CD007400. doi: 10.1002/14651858.CD007400.pub3. Epub 2016 Apr 22. PMID: 27103611; PMCID: PMC6494263.
* Uchino T, Miyazaki Y, Ishikawa A, Kagawa Y. Development of a Novel Simple Gel Formulation Containing an Ion-Pair Complex of Diclofenac and Phenylephrine. Skin Pharmacol Physiol. 2019;32(6):318-327. doi: 10.1159/000501734. Epub 2019 Oct 15. PMID: 31614350.
* van Herwaarden N, van den Elsen GAH, de Jong ICA, Kramers CK, Kloppenburg M, van den Bemt BJF. [Topical NSAIDs: ineffective or undervalued?]. Ned Tijdschr Geneeskd. 2021 May 19;165. Epub 2021 May 19. PMID: 34346575.
* Li LP, Jin YC, Fang L, Zhang C. Direct photolysis of diclofenac under simulated sunlight: Transformation pathway and biological concerns. Chemosphere. 2022 Nov;307(Pt 1):135775. doi: 10.1016/j.chemosphere.2022.135775. Epub 2022 Jul 19. PMID: 35868525.
* Santhosh A, Sharma A, Bakhshi S, Kumar A, Sharma V, Malik PS, Pramanik R, Gogia A, Prasad CP, Sehgal T, Gund S, Dev A, Cheung WY, Pandey RM, Kumar S, Gupta I, Batra A, D-TORCH Trial Investigators. Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial. J Clin Oncol. 2024 May 20;42(15):1821-1829. doi: 10.1200/JCO.23.01730. Epub 2024 Feb 27. PMID: 38412399.
* Khankhel N, Friedman BW, Baer J, Lopez L, Feliciano C, Lee S, Irizarry E. Topical Diclofenac Versus Oral Ibuprofen Versus Diclofenac + Ibuprofen for Emergency Department Patients With Acute Low Back Pain: A Randomized Study. Ann Emerg Med. 2024 Jun;83(6):542-551. doi: 10.1016/j.annemergmed.2024.01.037. Epub 2024 Mar 2. PMID: 38441515; PMCID: PMC11141689.
* Chen ZR, Chen BK, Li P, Feng K. Efficacy and safety of different topical diclofenac formulations for the treatment of knee osteoarthritis: a meta-analysis of short-term and long-term treatment comparisons. BMC Musculoskelet Disord. 2025 Mar 10;26(1):230. doi: 10.1186/s12891-025-08465-7. Epub 2025 Mar 10. PMID: 40065343; PMCID: PMC11892197.
* Singh P, Shah J, Pimple P. Formulation and In-Vivo Evaluation of Aceclofenac and Quercetin Nanoemulsion-Based Gel Against Rheumatoid Arthritis. Immunol Invest. 2026 Jan;55(1):92-119. doi: 10.1080/08820139.2025.2581581. Epub 2025 Oct 30. PMID: 41168170.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.